That's for 2016 which means RXSF should be trading there in 2015! We are already $12 behind! Do you see where the numbers, using his figures and RXSFs projected 3 year revenues and EBITDA would put the 2016 and 2017 PPS with the financing? With no toxic CDs coming this will be well in to the $50+ range sometime in 2016!
CEO said she is commissioning more reports throughout the year, so she is doing this right! It helps validate her decisions IMHO. Just more info for us. Transparent.